Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aptamers as targeted therapeutics: current potential and challenges.

Literature DB >> 28450742

Aptamers as targeted therapeutics: current potential and challenges.

Jiehua Zhou, John Rossi.

Abstract

Year: 2017 PMID： 28450742 DOI： 10.1038/nrd.2017.86

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

× No keyword cloud information.

1 in total

Review 1. Aptamers as targeted therapeutics: current potential and challenges.

Authors: Jiehua Zhou; John Rossi
Journal: Nat Rev Drug Discov Date: 2016-11-03 Impact factor: 84.694

1 in total

40 in total

1. DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement.

Authors: Junhua Mai; Xin Li; Guodong Zhang; Yi Huang; Rong Xu; Qi Shen; Ganesh L Lokesh; Varatharasa Thiviyanathan; Lingxiao Chen; Haoran Liu; Youli Zu; Xiaojing Ma; David E Volk; David G Gorenstein; Mauro Ferrari; Haifa Shen
Journal: Mol Pharm Date: 2018-03-26 Impact factor: 4.939

2. Time-lapse imaging of molecular evolution by high-throughput sequencing.

Authors: Nam Nguyen Quang; Clément Bouvier; Adrien Henriques; Benoit Lelandais; Frédéric Ducongé
Journal: Nucleic Acids Res Date: 2018-09-06 Impact factor: 16.971

Review 3. Aptamers and apple pies: a mini-review of PSMA aptamers and lessons from Donald S. Coffey.

Authors: Shawn E Lupold
Journal: Am J Clin Exp Urol Date: 2018-04-01

4. An RNA Aptamer-Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients.

Authors: Suresh Veeramani; Sue E Blackwell; William H Thiel; Zhi-Zhang Yang; Stephen M Ansell; Paloma H Giangrande; George J Weiner
Journal: Cancer Immunol Res Date: 2019-08-05 Impact factor: 11.151

5. Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown.

Authors: Ying Zhang; Xuemei Xie; Pourya Naderi Yeganeh; Dian-Jang Lee; David Valle-Garcia; Karla F Meza-Sosa; Caroline Junqueira; Jiayu Su; Hongbo R Luo; Winston Hide; Judy Lieberman
Journal: Proc Natl Acad Sci U S A Date: 2021-03-02 Impact factor: 11.205

Aptamers as targeted therapeutics: current potential and challenges.

Review 1. Aptamers as targeted therapeutics: current potential and challenges.

1. DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement.

2. Time-lapse imaging of molecular evolution by high-throughput sequencing.

Review 3. Aptamers and apple pies: a mini-review of PSMA aptamers and lessons from Donald S. Coffey.

4. An RNA Aptamer-Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients.

5. Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown.

Review 6. MicroRNA function in craniofacial bone formation, regeneration and repair.

7. Clinical Potential of Nerve Input to Tumors: A Bioelectricity Perspective.

8. Protein Labeling and Crosslinking by Covalent Aptamers.

Review 9. Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction.

10. DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells.